Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,253 | 7,194 | N/A | N/A | N/A |
| Other current assets | 853 | 0 | 0 | 0 | 0 |
| TOTAL | $10,994 | $12,390 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 585 | 510 | N/A | N/A | N/A |
| Other Non-Current Assets | 84 | 84 | 0 | 0 | 0 |
| TOTAL | $669 | $594 | $N/A | $N/A | $N/A |
| Total Assets | $11,662 | $12,984 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,329 | 833 | 0 | 0 | 0 |
| Accrued Expenses | 8,792 | 3,595 | N/A | N/A | N/A |
| Other current liabilities | 2,676 | 1,482 | N/A | N/A | N/A |
| TOTAL | $16,798 | $5,910 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $16,798 | $5,910 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -95,480 | -64,185 | N/A | N/A | N/A |
| Other shareholders' equity | -1,523 | -1,303 | 0 | 0 | 0 |
| TOTAL | $-5,135 | $7,074 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $11,662 | $12,984 | $0 | $0 | $0 |